FAQ/Help |
Calendar |
Search |
Today's Posts |
04-29-2010, 09:58 AM | #1 | |||
|
||||
Magnate
|
UCB Receives Complete Response Letter from U.S. FDA Regarding NeuproŽ (Rotigotine)
23-Apr-2010 18:00 pm CET | Brussels (Belgium)
Full press release content: http://www.ucb.com/media-room/newsdetail/?det=1407441
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
NEWS: UCB Announces The U.S. Launch Of Neupro (Rotigotine Transdermal System) | Parkinson's Disease | |||
Rotigotine transdermal patch appears safe | Parkinson's Disease |